What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?
Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical Inc. (LFCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wynnefield Capital Nelson Obus | 4,703,216 | $33,110,640 | 20.95% | |
| 2. | Legion Partners Asset Management Ted White And Christopher Kiper | 4,431,823 | $31,200,034 | 20.71% | |
| 3. | Greenhaven Road Investment Management Scott Stewart Miller | 3,616,146 | $25,457,668 | 10.38% | |
| 4. | 325 Capital Michael Braner, Daniel Friedberg And Anil Shrivastava | 2,162,466 | $15,223,761 | 6.31% | |
| 5. | Millennium Management Israel Englander | 100,813 | $709,724 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.74 | 17,000 | $97,580.00 | 559,717 | 2025-01-08 | Filing | |
| $4.10 | 169,753 | $695,987.30 | 2,607,433 | 2024-10-03 | Filing | |
| $4.10 | 122,930 | $504,013.00 | 2,095,783 | 2024-10-03 | Filing | |
| $4.10 | 152,102 | $623,618.20 | 319,286 | 2024-10-03 | Filing | |
| $4.10 | 1,311,312 | $5,376,379.20 | 4,084,268 | 2024-10-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.12 | 150,419 | $1,071,554.87 | 264,180 | 2025-05-28 | Filing | |
| $6.50 | 1,139,504 | $7,411,561.92 | 414,599 | 2025-05-27 | Filing | |
| $6.75 | 96,137 | $649,386.21 | 1,554,103 | 2025-05-23 | Filing | |
| $7.00 | 12,334 | $86,352.80 | 1,650,240 | 2025-05-13 | Filing | |
| $7.03 | 45,698 | $321,426.02 | 1,662,574 | 2025-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,755,161 | $29,820,465 | 20% | |
| 2. | 1,764,919 | $12,425,030 | 0% | |
| 3. | 1,546,617 | $10,888,184 | 0% | |
| 4. | 750,498 | $5,285,211 | 0% | |
| 5. | 728,511 | $5,128,721 | 0% |
News See All
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. During the call, all participants will be in a listen-only mode.
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Micro Cap Stocks to Buy Now
Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises.
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining LifeCor's financial 2025 second quarter earnings call. During the call, all participants will be in a listen-only mode.
Here’s Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Arquitos Capital Management, an investment management firm, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lifecore's Fiscal 2025 First Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Lifecore Biomedical Q4 and Full Year 2024 Earnings Call. At this time all participants are in a listen-only mode.